FDA Inspection 808764 — Center for Reproductive Health and Gynecology
The FDA completed an inspection of Center for Reproductive Health and Gynecology on November 30, 2012 in Beverly Hills, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 30, 2012
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Beverly Hills, CA (United States)